100400mg Velasof Velpatasvir Sofosbuvir Tablets

100400mg Velasof Velpatasvir Sofosbuvir Tablets Specification

Salt Composition
Velpatasvir 100 mg, Sofosbuvir 400 mg

Indication
Chronic Hepatitis C infection

Dosage Form
Tablet

Enzyme Types
NS5A Inhibitor, NS5B Polymerase Inhibitor

Feature
Oral fixed dose combination

Application
Antiviral therapy for Hepatitis C

Ph Level
Neutral (pharmaceutical grade)

Physical Color/Texture
Film-coated tablet

Fermentation Smell
Odorless/none

Enzymatic Activity
Not an enzyme product

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Packaging Size
28 Tablets

Treatment
Mild to moderate Covid-19

Strength
400mg/100mg

Tablet Shape
Oval

Prescription
Prescription Only

Administration Route
Oral

PCD Pharma
Also gives PCD Pharma

Film Coating
Yes

Blister Pack
Yes

100400mg Velasof Velpatasvir Sofosbuvir Tablets Trade Information

Minimum Order Quantity
50 Pieces

Supply Ability
500 Pieces Per Month

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About 100400mg Velasof Velpatasvir Sofosbuvir Tablets

Redeem superior antiviral therapy with the grandiose 100/400mg Velasof Velpatasvir Sofosbuvir Tablets. This prescription-only combination stands as a trending option for treating mild to moderate Covid-19 and chronic Hepatitis C infection in India. Boasting unparalleled efficacy, each oval, film-coated tablet contains Velpatasvir 100mg and Sofosbuvir 400mg, expertly crafted to target NS5A and NS5B enzymes. Packed in secure blister packs (28 tablets), this lofty oral formulation is odorless and offers a neutral pH. Get exceptional performance and a shelf life of 24 months. Also available for PCD Pharma partnerships.

Explore Notable Features and Versatile Applications

100/400mg Velasof Velpatasvir Sofosbuvir Tablets offer an oral, fixed-dose combination, setting them apart with their film-coated exterior and neutral pharmaceutical pH. These tablets are ideal for treating chronic Hepatitis C and mild to moderate Covid-19, ensuring high effectiveness in clinical and outpatient settings. Their oval shape, odorless quality, and blister packaging enhance patient compliance. The material features include excellent stability and protection from moisture, making them suitable for hospitals, clinics, and pharmacies.

Comprehensive Packaging and Efficient Shipment Policies

Velasof tablets are supplied in blister packs of 28, each designed to ensure product integrity during shipment and storage. Payment terms are flexible to accommodate diverse clients, with samples available under set policies for quality assurance prior to purchase. Upon order, shipment is prepared promptly to guarantee swift arrival, and the exchange process is straightforward should any issue arise. Clients benefit from reliable delivery and customer-centric service for exporters, suppliers, and traders.

FAQ's of 100400mg Velasof Velpatasvir Sofosbuvir Tablets:

Q: How should 100/400mg Velasof Velpatasvir Sofosbuvir Tablets be administered?

A: These tablets are taken orally as per your healthcare provider's prescription, typically once daily, with or without food.

Q: What conditions do Velasof Velpatasvir Sofosbuvir Tablets treat?

A: They are indicated for antiviral therapy in chronic Hepatitis C infection and also aid in treating mild to moderate Covid-19 cases.

Q: When can I expect my shipment to arrive after placing an order?

A: Once your order is confirmed, shipment is processed promptly to ensure timely arrival, with delivery timelines depending on your location.

Q: Where should I store these tablets to maintain their shelf life?

A: Store the tablets below 30C, protected from moisture, to preserve their efficacy for up to 24 months.

Q: What is the main benefit of this oral fixed-dose combination?

A: The combination delivers unparalleled antiviral effectiveness with convenient once-daily dosing, boosting patient compliance and clinical outcomes.

Tell us about your requirement